Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Multiple Myeloma of Bone (Diagnosis)”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)UnknownNCT00008307
What this trial is testing

Combination Chemotherapy Followed by Donor Bone Marrow Transplant or Peripheral Stem Cell Transplant in Treating Patients With Hematologic Cancer or Genetic Disorders

Who this might be right for
LeukemiaLymphomaMultiple Myeloma and Plasma Cell Neoplasm+1 more
Herbert Irving Comprehensive Cancer Center 52
Not applicableLooking for participantsNCT07403630
What this trial is testing

INTEGRATIVE "MULTI-OMICS" AND FUNCTIONAL PLATFORM FOR THE COMPLETE DIAGNOSTIC CHARACTERIZATION OF TUMORS: THE ITALIAN TUMOR CHEMOGENOMIC PROFILER (IT-TCP)

Who this might be right for
Acute LeukemiaMultiple MyelomaSquamous Cell Carcinoma+9 more
Azienda Ospedaliero-Universitaria di Parma 300
Early research (Phase 1)Study completedNCT00161187
What this trial is testing

Irradiated Donor Lymphocyte Infusion in Treating Patients With Relapsed or Refractory Hematologic Cancer or Solid Tumor

Who this might be right for
Cancer
University of Medicine and Dentistry of New Jersey 37
Large-scale testing (Phase 3)Study completedNCT00004230
What this trial is testing

Captopril in Treating Patients Undergoing Bone Marrow or Stem Cell Transplantation

Who this might be right for
Cancer
Northwestern University 35
Not applicableEnded earlyNCT00949052
What this trial is testing

Genetic Susceptibility and Risk of Second Cancers in Patients Who Have Undergone Stem Cell Transplant for Cancer

Who this might be right for
Cancer
Vanderbilt-Ingram Cancer Center 1,000
Large-scale testing (Phase 3)UnknownNCT00002989
What this trial is testing

Combination Chemotherapy With or Without Idarubicin and Peripheral Stem Cell Transplantation in Treating Patients With Leukemia or Myelodysplastic Syndrome

Who this might be right for
LeukemiaLymphomaMultiple Myeloma and Plasma Cell Neoplasm+1 more
European Organisation for Research and Treatment of Cancer - EORTC 207
Testing effectiveness (Phase 2)Study completedNCT00530218
What this trial is testing

Ganciclovir by Infusion and by Mouth in Treating Patients With Cytomegalovirus After Donor Bone Marrow Transplant

Who this might be right for
Myelodysplastic/Myeloproliferative Neoplasm, UnclassifiableLeukemiaLymphoma+3 more
City of Hope Medical Center 61
Not applicableStudy completedNCT00001582
What this trial is testing

Investigation of the Human Immune Response in Normal Subjects and Patients With Disorders of the Immune System and Cancer

Who this might be right for
T-cell LymphomaB-Cell LymphomaATL+1 more
National Cancer Institute (NCI) 902
Testing effectiveness (Phase 2)UnknownNCT00598624
What this trial is testing

Clinical Trial to Evaluate the Safety and Efficacy of Treosulfan Based Conditioning Prior to Allogeneic Haematopoietic Stem Cell Transplantation (HSCT)

Who this might be right for
LeukemiaChronic Myeloid LeukemiaMyelodysplastic Syndrome+4 more
IRCCS San Raffaele 175
Post-approval studies (Phase 4)Study completedNCT00029224
What this trial is testing

Treatment With Zoledronic Acid in Patients With Breast Cancer, Multiple Myeloma, and Prostate Cancer With Cancer Related Bone Lesions

Who this might be right for
Breast CancerMultiple MyelomaProstate Cancer
Novartis 500
Testing effectiveness (Phase 2)Study completedNCT00237627
What this trial is testing

Doxorubicin Hydrochloride Liposome and Bortezomib in Treating Patients With Refractory Hematologic Cancer or Malignant Solid Tumor or Metastatic Breast Cancer

Who this might be right for
Breast CancerLeukemiaLymphoma+3 more
UNC Lineberger Comprehensive Cancer Center 107
Testing effectiveness (Phase 2)Study completedNCT01384513
What this trial is testing

A Two-Step Approach to Reduced Intensity Bone Marrow Transplant for Patients With Hematological Malignancies

Who this might be right for
Adult Acute Lymphoblastic Leukemia in RemissionAdult Acute Myeloid Leukemia in RemissionAdult Acute Myeloid Leukemia With 11q23 (MLL) Abnormalities+44 more
Sidney Kimmel Comprehensive Cancer Center at Thomas Jefferson University 40
Testing effectiveness (Phase 2)Active Not RecruitingNCT04174196
What this trial is testing

Lenalidomide and CC-486 With Radiation Therapy in Patients With Plasmacytoma

Who this might be right for
PlasmacytomaPlasmacytoma of BoneMultiple Myeloma
Memorial Sloan Kettering Cancer Center 21
Large-scale testing (Phase 3)Study completedNCT00001561
What this trial is testing

Active Immunization of Sibling Bone Marrow Transplant Donors Against Purified Myeloma Protein of the Recipient Undergoing Allogeneic Bone Marrow Transplantation

Who this might be right for
Graft vs Host DiseaseMultiple Myeloma
National Cancer Institute (NCI) 30
Not applicableEnded earlyNCT01076270
What this trial is testing

Plerixafor and Filgrastim For Mobilization of Donor Peripheral Blood Stem Cells Before A Donor Peripheral Blood Stem Cell Transplant in Treating Patients With Hematologic Malignancies

Who this might be right for
Accelerated Phase Chronic Myelogenous LeukemiaAdult Acute Lymphoblastic Leukemia in RemissionAdult Acute Myeloid Leukemia in Remission+80 more
Fred Hutchinson Cancer Center 1
Testing effectiveness (Phase 2)Looking for participantsNCT05805605
What this trial is testing

Allo HSCT Using RIC and PTCy for Hematological Diseases

Who this might be right for
Acute Myelogenous LeukemiaAcute Lymphocytic LeukemiaBiphenotypic Acute Leukemia+15 more
Masonic Cancer Center, University of Minnesota 56
Testing effectiveness (Phase 2)UnknownNCT00048464
What this trial is testing

T Cell Immunotherapy for Multiple Myeloma Patients Undergoing a Bone Marrow Transplant

Who this might be right for
Multiple Myeloma
Xcyte Therapies 35
Testing effectiveness (Phase 2)Study completedNCT01852799
What this trial is testing

PAD Followed by Autologous Stem Cell Transplantation (ASCT) to Treat Newly Diagnosed Multiple Myeloma

Who this might be right for
Multiple Myeloma
Shanghai Changzheng Hospital 18
Early research (Phase 1)Study completedNCT00299767
What this trial is testing

Phase I Study of Sequential Cord Blood Transplants

Who this might be right for
LymphomaLeukemiaMultiple Myeloma+1 more
Massachusetts General Hospital 21
Early research (Phase 1)Ended earlyNCT01908387
What this trial is testing

Phase 1 Study of CC-486 in Japanese Subjects With Hematological Neoplasms

Who this might be right for
Myelodysplastic SyndromesChronic Myelomonocytic LeukemiaAcute Myeloid Leukemia+3 more
Celgene Corporation 2
Next Page